Strategic Education Inc (STRA) (Q3 2026) Earnings Call Highlights: Healthcare and ETS

Strategic Education Inc (STRA) reported Q3 2026 results with Education Technology Services revenue up 12% to $43M and U.S. Healthcare enrollment growing 9%. However, Australia segment revenue declined 7% due to international student restrictions, and consolidated revenue was flat at $320M. The company expects 2027 revenue to be flat and sees margin pressure in ETS and U.S. Higher Education.

Original reporting
Published Nov 10, 2026, 7:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 7:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Strategic Education Inc (STRA) (Q3 2026) Earnings Call Highlights: Healthcare and ETS — source image
Decision brief

The 30-second read

$STRABearishMed
01

Why it matters

The earnings release signals short‑term weakness but highlights long‑term growth areas in healthcare education.

02

Market read

Earnings miss and impairment create near‑term downside risk, while healthcare enrollment growth offers a potential upside catalyst.

03

What to watch

The $50M 2027 investment plan may drive future high‑margin growth in ETS and U.S. healthcare.

Relevance 7/10Novelty 7/10Timing: post‑earnings today

Background

Strategic Education operates Strayer University and Capella University, focusing on higher‑education and healthcare training.

Company-level read

Ticker impact

$STRABearishHigh confidence
Context

Q3 2026 earnings call disclosed flat revenue, modest margin compression and a $134M goodwill impairment in Australia.

Expected impact

likely downward pressure as investors price in flat revenue and higher expenses

Evidence & confidence

The company reported flat consolidated revenue, a decline in operating income, and a large non‑cash impairment, all of which are fresh negative catalysts.

Market effects

Education services and healthcare‑focused education may see heightened scrutiny as margins compress.

Australian education segment faces regulatory headwinds, potentially affecting other providers in the region.

Limited; primarily impacts U.S. and Australian education investors.

Counterpoint

If the healthcare enrollment growth sustains, the company could rebound once margin pressure eases.

Key entities

  • Carl McDonnell

    Provided guidance on segment outlook and growth investments.

  • Daniel Jackson

    Commented on margin expectations and expense growth.

Related articles

$STRAMed

Strategic Education Earnings Call Signals Recovery Amid Pressure

Strategic Education (STRA) reported mixed Q3 results, with EPS up 4% to $1.69 and free cash flow up 8% to $137M. Revenue was flat at $320M, and operating income declined 2%. Growth areas included Education Technology Services and healthcare enrollment, while Australian international restrictions and a $134M impairment weighed on results. Management expects flat 2027 revenue and plans increased investments in healthcare and education technology.

$STRAMed

What Strategic Education (STRA) Said on Its Q3 Earnings Call

Strategic Education (STRA) reported a 1% decline in U.S. Higher Education enrollment, driven by international student visa issues. Domestic enrollment grew 9%, and the company plans campus expansions. Technology and Healthcare segments drove revenue growth, with Education Technology Services up 12% and Healthcare enrollment up 9%. STRA repurchased 347,000 shares and has $139M in cash.

$STRAMed

Strategic Education (STRA) Q3 2026 Earnings Call Transcript

Strategic Education (STRA) reported Q3 2026 results. Free cash flow rose 8% to $137M. Education Technology Services revenue grew 12% to $43M, with operating margin expanding 80 bps. Sophia Learning subscribers increased 22%, and revenue grew 20%. U.S. Higher Education enrollment fell 1% to 84,700, but healthcare enrollment grew 9%. Australia saw a 9% enrollment decline due to government restrictions, leading to a $134M impairment.

$STRAHighAI 8/10

Why Strategic Education (STRA) shares are plunging today

Strategic Education (STRA) shares fell 17.1% after reporting a Q3 loss due to a $134.1M impairment charge related to Torrens University. Revenue increased slightly, but adjusted earnings of $1.72 missed estimates. The company maintained its dividend. STRA is down 20.3% YTD and 29.6% below its 52-week high.

$STRAMed

Strategic Education Reports Q3 2026 Results, $1.69 Adjusted EPS

Strategic Education reported Q3 2026 revenue of $325.1M, up 1.6% YoY, and adjusted EPS of $1.69. A $134.1M impairment charge led to an operating loss of $87.6M. Enrollment declined in U.S. Higher Education and Australia/New Zealand, while Sophia Learning and Education Technology Services grew. The company declared a $0.60 quarterly dividend.